President Trump's announcement last week linking Tylenol with autism could play a role in ongoing legal cases against the company that makes it.

One lawyer representing patients who say they were harmed by the drug says his firm has gotten an influx of more than a thousand calls this week from potential new clients asking for information.

"A lot of inbound calls have come in, as you would expect now that a very bright spotlight has been put on this issue," says attorney Ashley Keller, whose firm Keller Postman is representing people in a product liability lawsuit against the drugmaker Kenvue.

The Trump administration's attention to the issue has also given the firm new ammunition in its appeal of the lawsuit, though the courts had effectively shot it down almost two years ago.

The pres

See Full Page